Xu Feng1, Li Beiping2. 1. Associate Professor, Department of Anaesthesiology, Xuzhou First People's Hospital, Xuzhou, Jiangsu, China. 2. Chief Physician, Department of Anaesthesiology, Xuzhou First People's Hospital, Xuzhou, Jiangsu, China.
Abstract
INTRODUCTION: Suffering from osteoarthritis is prevalent among elderly patients so the use of intra-articular injection of medical ozone may well be the effective way to relieve their pain. AIM: To evaluate the effect of intra-articular injection of medical ozone given into the knee of the osteoarthritis patients, and to compare it with taking celecoxib and glucosamine orally. MATERIALS AND METHODS: In the present study, 76 patients suffering from osteoarthritis were randomly assigned into two groups. In the ozone group, 20 ml ozone-oxygen mixture gas concentration of 20 μg/ml was injected into knee articular cavity and each patient took oral celecoxib and glucosamine hydrochloride. Patients in control group only took the celecoxib and glucosamine hydrochloride orally.Pain score and Lysholm knee score were measured prior to the injection (pretreatment) and at one, three, six weeks after the beginning of the treatment (posttreatment). RESULTS: After the treatment, the pain intensity and function significantly improved in the two groups compared with the pretreatment (p<0.05). In the ozone group, three weeks after intervention, the pain score improved significantly when compared with the control group (p<0.05).After the treatment, the lysholm scores increased significantly (p<0.05), but in the ozone group, it improved faster. CONCLUSION: Intra-articular injection of ozone plus oral celecoxib and glucosamine could significantly decrease pain intensity in patients with mild to moderate Knee Osteoarthritis (KOA), and improve their functional status early than oral celecoxib and glucosamine only.
INTRODUCTION: Suffering from osteoarthritis is prevalent among elderly patients so the use of intra-articular injection of medical ozone may well be the effective way to relieve their pain. AIM: To evaluate the effect of intra-articular injection of medical ozone given into the knee of the osteoarthritis patients, and to compare it with taking celecoxib and glucosamine orally. MATERIALS AND METHODS: In the present study, 76 patients suffering from osteoarthritis were randomly assigned into two groups. In the ozone group, 20 ml ozone-oxygen mixture gas concentration of 20 μg/ml was injected into knee articular cavity and each patient took oral celecoxib and glucosamine hydrochloride. Patients in control group only took the celecoxib and glucosamine hydrochloride orally.Pain score and Lysholm knee score were measured prior to the injection (pretreatment) and at one, three, six weeks after the beginning of the treatment (posttreatment). RESULTS: After the treatment, the pain intensity and function significantly improved in the two groups compared with the pretreatment (p<0.05). In the ozone group, three weeks after intervention, the pain score improved significantly when compared with the control group (p<0.05).After the treatment, the lysholm scores increased significantly (p<0.05), but in the ozone group, it improved faster. CONCLUSION: Intra-articular injection of ozone plus oral celecoxib and glucosamine could significantly decrease pain intensity in patients with mild to moderate Knee Osteoarthritis (KOA), and improve their functional status early than oral celecoxib and glucosamine only.
Authors: A Giombini; F Menotti; A Di Cesare; F Giovannangeli; M Rizzo; S Moffa; F Martinelli Journal: J Biol Regul Homeost Agents Date: 2016 Apr-Jun Impact factor: 1.711
Authors: Karen K Briggs; Jack Lysholm; Yelverton Tegner; William G Rodkey; Mininder S Kocher; J Richard Steadman Journal: Am J Sports Med Date: 2009-03-04 Impact factor: 6.202
Authors: Olivier Bruyère; Cyrus Cooper; Nigel Arden; Jaime Branco; Maria Luisa Brandi; Gabriel Herrero-Beaumont; Francis Berenbaum; Elaine Dennison; Jean-Pierre Devogelaer; Marc Hochberg; John Kanis; Andrea Laslop; Tim McAlindon; Susanne Reiter; Pascal Richette; René Rizzoli; Jean-Yves Reginster Journal: Drugs Aging Date: 2015-03 Impact factor: 3.923
Authors: Marc C Hochberg; Johanne Martel-Pelletier; Jordi Monfort; Ingrid Möller; Juan Ramón Castillo; Nigel Arden; Francis Berenbaum; Francisco J Blanco; Philip G Conaghan; Gema Doménech; Yves Henrotin; Thomas Pap; Pascal Richette; Allen Sawitzke; Patrick du Souich; Jean-Pierre Pelletier Journal: Ann Rheum Dis Date: 2015-01-14 Impact factor: 19.103
Authors: Alessandro de Sire; Francesco Agostini; Lorenzo Lippi; Massimiliano Mangone; Simone Marchese; Carlo Cisari; Andrea Bernetti; Marco Invernizzi Journal: Biomolecules Date: 2021-02-26
Authors: Teresa Paolucci; Francesco Agostini; Andrea Bernetti; Marco Paoloni; Massimiliano Mangone; Valter Santilli; Letizia Pezzi; Rosa Grazia Bellomo; Raoul Saggini Journal: J Int Med Res Date: 2021-02 Impact factor: 1.671